Trupanion Inc. (TRUP)

Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM, TRUP, EIG and AMSF.

Trupanion (TRUP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates...

In this episode of the Motley Fool Scoreboard, analysts evaluate Trupanion (TRUP -25.49%) and its potential as a pet insurance leader. With a solid track record and a growing market, is Trupanion a sm...

Trupanion, Inc. (NASDAQ:TRUP ) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET Company Participants Gil Melchior - Director of Investor Relations Margi Tooth - President and Chief Execut...

Although the revenue and EPS for Trupanion (TRUP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall St...

Trupanion (TRUP) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.05 per share a year ago.

Trupanion (TRUP -2.42%), a leader in pet medical insurance, released its Q4 2024 earnings on February 19, 2025. The company delivered mixed results, with earnings per share (EPS) at $0.04, missing ana...

Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Trupanion (TRUP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Stifel raised the firm's price target on Trupanion to $44 from $42 and keeps a Hold rating on the shares. Risk-based capital requirements for the company increased modestly quarter-over-quarter follow...